BRPI0317188A2 - Novo derivado de 2,4-diamino-1,3,5-triazina - Google Patents

Novo derivado de 2,4-diamino-1,3,5-triazina

Info

Publication number
BRPI0317188A2
BRPI0317188A2 BR0317188-4A BRPI0317188A BRPI0317188A2 BR PI0317188 A2 BRPI0317188 A2 BR PI0317188A2 BR PI0317188 A BRPI0317188 A BR PI0317188A BR PI0317188 A2 BRPI0317188 A2 BR PI0317188A2
Authority
BR
Brazil
Prior art keywords
diamino
new
triazine derivative
pharmaceutically acceptable
general formula
Prior art date
Application number
BR0317188-4A
Other languages
English (en)
Inventor
Shiro Maeda
Toshiko Kita
Kanji Meguro
Original Assignee
Hamari Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamari Chemicals Ltd filed Critical Hamari Chemicals Ltd
Publication of BRPI0317188A2 publication Critical patent/BRPI0317188A2/pt
Publication of BRPI0317188A8 publication Critical patent/BRPI0317188A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"NOVO DERIVADO DE 2,4-DIAMINO-1,3,5-TRIAZINA". A presente invenção se refere a um agente antibactericida, que compreende como ingrediente ativo um composto representado pela seguinte fórmula geral (1): ou um sal farmaceuticamente aceitável do mesmo.
BRPI0317188A 2002-12-17 2003-12-16 novo derivado de 2,4-diamino-1,3,5-triazina BRPI0317188A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002365927 2002-12-17
JP2003363820 2003-10-23
PCT/JP2003/016131 WO2004054989A1 (ja) 2002-12-17 2003-12-16 新規２，４−ジアミノ−１，３，５−トリアジン誘導体

Publications (2)

Publication Number Publication Date
BRPI0317188A2 true BRPI0317188A2 (pt) 2005-11-01
BRPI0317188A8 BRPI0317188A8 (pt) 2018-05-08

Family

ID=32599275

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0317188A BRPI0317188A8 (pt) 2002-12-17 2003-12-16 novo derivado de 2,4-diamino-1,3,5-triazina

Country Status (11)

Country Link
US (1) US7622469B2 (pt)
EP (1) EP1574503B1 (pt)
JP (1) JP4391422B2 (pt)
KR (1) KR101027366B1 (pt)
AU (1) AU2003289375A1 (pt)
BR (1) BRPI0317188A8 (pt)
CA (1) CA2510468C (pt)
ES (1) ES2403141T3 (pt)
MX (1) MXPA05006450A (pt)
NZ (1) NZ540972A (pt)
WO (1) WO2004054989A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE489370T1 (de) * 2005-06-14 2010-12-15 Schering Corp Herstellung und verwendung von verbindungen als aspartylproteasehemmer
FR2896161B1 (fr) * 2006-01-13 2008-04-04 Merck Sante Soc Par Actions Si Utilisation de derives de triazines pour fabriquer un medicament ayant un effet cicatrisant ou angiogenique.
DE102007054416A1 (de) * 2007-11-13 2009-05-14 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind
DE102008007314A1 (de) * 2008-02-02 2009-08-06 Merck Patent Gmbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-triazinderivaten
US20110124860A1 (en) * 2008-05-23 2011-05-26 Aubourg Stephanie Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives
WO2010024225A1 (ja) 2008-08-25 2010-03-04 浜理薬品工業株式会社 新規ジヒドロトリアジン誘導体
KR102061390B1 (ko) 2014-04-17 2019-12-31 이뮤노메트테라퓨틱스 인코포레이티드 구아니딘 화합물 및 그의 용도
KR102216701B1 (ko) 2014-11-20 2021-02-18 이뮤노메트테라퓨틱스 인코포레이티드 바이구아나이드 화합물 및 이의 용도
DE102018220631A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
DE102018220624A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
CN112642410A (zh) * 2020-12-01 2021-04-13 中国工程物理研究院核物理与化学研究所 一种用于水体中铀提取的抗菌聚合物纤维及其制备方法
DE102023201126A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Dihydrotriazinverbindung sowie Zusammensetzung zur Anwendung in der Podologie, bei der Prophylaxe und/oder Behandlung von Fußerkrankungen, der Behandlung von Tätowierungen und/oder Tätowierungswunden sowie der Behandlung eines Piercings und/oder von Piercing-Wunden
DE102023201127A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Medizinprodukt und Verfahren zur Herstellung des Medizinprodukts
DE102023201122A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Antimikrobiell wirksames Produkt

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168519A (en) 1961-10-17 1965-02-02 American Cyanamid Co 1-alkylphenyl-2, 2-di lower alkyl-4, 6-diimino-hexahydro-s-triazines
US3287365A (en) 1963-12-24 1966-11-22 American Cyanamid Co Novel dihydro-s-triazines and method of preparation
US3287366A (en) * 1963-12-24 1966-11-22 American Cyanamid Co Novel 1, 2-dihydro-s-triazines
DE1620178A1 (de) 1965-12-03 1970-03-12 Ruhrchemie Ag Verfahren zur Herstellung von Aminoalkylamino-s-triazinen
JPS4541591B1 (pt) 1967-12-11 1970-12-26
US5565451A (en) 1994-09-15 1996-10-15 Fmc Corporation 1-substituted-2, 4-diamino-6, 6-dialkyl-1, 6-dihydro-1, 3, 5-triazines as insecticides
WO1999001442A1 (en) 1997-07-02 1999-01-14 Zeneca Limited Triazine derivatives and their use as antibacterial agents
DE69928282T2 (de) 1998-12-01 2006-06-29 Bayer Cropscience Ag Substituierte 1,3,5-triazine als herbizide
FR2804113B1 (fr) 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
WO2004087153A2 (en) * 2003-03-28 2004-10-14 Chiron Corporation Use of organic compounds for immunopotentiation

Also Published As

Publication number Publication date
EP1574503A1 (en) 2005-09-14
JP4391422B2 (ja) 2009-12-24
MXPA05006450A (es) 2005-08-19
BRPI0317188A8 (pt) 2018-05-08
EP1574503A4 (en) 2008-06-25
US7622469B2 (en) 2009-11-24
NZ540972A (en) 2009-03-31
CA2510468A1 (en) 2004-07-01
HK1076816A1 (en) 2006-01-27
KR20050085720A (ko) 2005-08-29
US20060154928A1 (en) 2006-07-13
EP1574503B1 (en) 2013-03-13
ES2403141T3 (es) 2013-05-14
WO2004054989A1 (ja) 2004-07-01
CA2510468C (en) 2011-01-04
KR101027366B1 (ko) 2011-04-11
ES2403141T8 (es) 2013-06-21
JPWO2004054989A1 (ja) 2006-04-20
AU2003289375A1 (en) 2004-07-09

Similar Documents

Publication Publication Date Title
BR0312729A (pt) Novos derivados de indol-3-enxofre
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
NO950297D0 (no) Prolinamidderivater
BR0212488A (pt) Combinações de herbicidas e protetores
BR0109703A (pt) Derivados de piperazina
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
BR0116217A (pt) Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
BRPI0317188A8 (pt) novo derivado de 2,4-diamino-1,3,5-triazina
UA94065C2 (en) Dihydropseudoerythromycin derivatives
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
BR0313917A (pt) Composições antimicrobianas
ATE322487T1 (de) Hydroxamsäure-derivate
CO5560555A2 (es) Cristales de derivado de hidroxinorefedrina
GB0212410D0 (en) Organic compounds
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
NO20070421L (no) Radiosensitiviserende middel
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2001282238A1 (en) Dihydroporphyrin derivatives and their uses
MXPA03011790A (es) Agente para la procteccion de neuronas de la retina.
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
SE9901062D0 (sv) Use for conifer sapling protection
TW200640464A (en) Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL